Aris P. Agouridis

1.2k total citations
54 papers, 804 citations indexed

About

Aris P. Agouridis is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Aris P. Agouridis has authored 54 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Epidemiology. Recurrent topics in Aris P. Agouridis's work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Aris P. Agouridis is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Aris P. Agouridis collaborates with scholars based in Greece, Cyprus and United Kingdom. Aris P. Agouridis's co-authors include Moses Elisaf, Theodosios D. Filippatos, Constantinos Tsioutis, Evangelos C. Rizos, Haralampos J. Milionis, Michael S. Kostapanos, Elizabeth O. Johnson, Eirini Agapidaki, Dimitrios Ntourakis and Christos V. Rizos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Atherosclerosis.

In The Last Decade

Aris P. Agouridis

48 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aris P. Agouridis Greece 17 301 223 150 125 101 54 804
Jan Hoong Ho United Kingdom 16 307 1.0× 219 1.0× 85 0.6× 195 1.6× 79 0.8× 46 846
Yanmei Huang China 16 149 0.5× 165 0.7× 113 0.8× 103 0.8× 167 1.7× 45 994
Jun Sasaki Japan 19 395 1.3× 269 1.2× 122 0.8× 177 1.4× 284 2.8× 67 1.1k
Yongyan Song China 16 221 0.7× 207 0.9× 167 1.1× 167 1.3× 261 2.6× 58 834
Caroline G. P. Roberts United States 13 174 0.6× 320 1.4× 105 0.7× 46 0.4× 194 1.9× 24 861
Marilu Fiegenbaum Brazil 17 277 0.9× 131 0.6× 85 0.6× 43 0.3× 176 1.7× 61 891
Imran Ali Khan Saudi Arabia 20 381 1.3× 289 1.3× 179 1.2× 129 1.0× 344 3.4× 130 1.5k
Rui Fan China 17 115 0.4× 92 0.4× 165 1.1× 124 1.0× 161 1.6× 43 740
Gemma Llauradó Spain 19 204 0.7× 339 1.5× 246 1.6× 215 1.7× 226 2.2× 57 1.1k
Ashok Kumar India 15 101 0.3× 158 0.7× 75 0.5× 191 1.5× 119 1.2× 107 736

Countries citing papers authored by Aris P. Agouridis

Since Specialization
Citations

This map shows the geographic impact of Aris P. Agouridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aris P. Agouridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aris P. Agouridis more than expected).

Fields of papers citing papers by Aris P. Agouridis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aris P. Agouridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aris P. Agouridis. The network helps show where Aris P. Agouridis may publish in the future.

Co-authorship network of co-authors of Aris P. Agouridis

This figure shows the co-authorship network connecting the top 25 collaborators of Aris P. Agouridis. A scholar is included among the top collaborators of Aris P. Agouridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aris P. Agouridis. Aris P. Agouridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makrigiannakis, Antonis, et al.. (2025). Pregnancy-associated plasma protein A (PAPP-A) as a first trimester serum biomarker for preeclampsia screening: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2448502–2448502. 2 indexed citations
2.
Liberopoulos, Evangelos, et al.. (2025). Classic lipid profile and lipoprotein(a) in systemic sclerosis: a systematic review and meta-analysis of case-control studies. Rheumatology International. 45(8). 182–182.
3.
Liontos, Angelos, et al.. (2025). High-density lipoprotein cholesterol and multiple sclerosis: a systematic review and meta-analysis. Archives of Medical Science - Atherosclerotic Diseases. 10(1). 69–77. 1 indexed citations
4.
5.
Vougiouklakis, G, et al.. (2025). Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand?. Pathogens. 14(11). 1119–1119.
6.
Ishak, Angela, et al.. (2024). Patient Experiences and Perceptions with Infections Due to Multidrug-Resistant Organisms: A Systematic Review. Pathogens. 13(9). 817–817. 2 indexed citations
7.
Agouridis, Aris P., Evangelia Ntzani, Georgia Anastasiou, Fotios Barkas, & Evangelos C. Rizos. (2024). Unravelling Beau's lines as a potential indicator of severe immune response in COVID-19 and reinfection. European Journal of Case Reports in Internal Medicine. 11(2). 4281–4281. 2 indexed citations
8.
Vougiouklakis, G, et al.. (2024). Herpes Simplex Virus Esophagitis in a Patient Receiving Long-Term Nasal Corticosteroids: A Rare Case. Cureus. 16(8). e66631–e66631. 1 indexed citations
9.
Barkas, Fotios, Petros P. Sfikakis, Evangelos Liberopoulos, et al.. (2023). Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?. SHILAP Revista de lepidopterología. 54. 1–6. 19 indexed citations
10.
Spernovasilis, Nikolaos, et al.. (2022). Infections Caused by Moellerella wisconsensis: A Case Report and a Systematic Review of the Literature. Microorganisms. 10(5). 892–892. 4 indexed citations
11.
Barkas, Fotios, et al.. (2022). The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine. 11(23). 6894–6894. 14 indexed citations
12.
Agouridis, Aris P., et al.. (2020). The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology. 33(3). 312–318. 7 indexed citations
13.
Tsioutis, Constantinos, et al.. (2019). Adrenal Aging and Its Implications on Stress Responsiveness in Humans. Frontiers in Endocrinology. 10. 54–54. 128 indexed citations
14.
15.
16.
Agouridis, Aris P., Christos V. Rizos, Moses Elisaf, & Theodosios D. Filippatos. (2013). Does Combination Therapy with Statins and Fibrates Prevent Cardiovascular Disease in Diabetic Patients with Atherogenic Mixed Dyslipidemia?. The Review of Diabetic Studies. 10(2-3). 171–190. 31 indexed citations
17.
18.
Agouridis, Aris P., Vasilis Tsimihodimos, Theodosios D. Filippatos, et al.. (2011). The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. Expert Opinion on Pharmacotherapy. 12(17). 2605–2611. 28 indexed citations
19.
Agouridis, Aris P., Theodosios D. Filippatos, Christos S. Derdemezis, D. P. Mikhailidis, & Moses Elisaf. (2010). Combination of Fenofibrate with Non-Statin Drug Regimens. Current Pharmaceutical Design. 16(30). 3401–3416. 16 indexed citations
20.
Kostapanos, Michael S., Haralambos Milionis, Aris P. Agouridis, Christos V. Rizos, & Moses Elisaf. (2009). Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. International Journal of Clinical Practice. 63(9). 1308–1313. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Hoong Ho Breakdown of academic impact, for papers by Yanmei Huang Breakdown of academic impact, for papers by Jun Sasaki Breakdown of academic impact, for papers by Yongyan Song Breakdown of academic impact, for papers by Caroline G. P. Roberts Breakdown of academic impact, for papers by Marilu Fiegenbaum Breakdown of academic impact, for papers by Imran Ali Khan Breakdown of academic impact, for papers by Rui Fan Breakdown of academic impact, for papers by Gemma Llauradó Breakdown of academic impact, for papers by Ashok Kumar
Rankless by CCL
2026